IBDEI2ZD ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,47595,1,4,0)
;;=4^R42.
;;^UTILITY(U,$J,358.3,47595,2)
;;=^5019450
;;^UTILITY(U,$J,358.3,47596,0)
;;=R45.86^^185^2408^40
;;^UTILITY(U,$J,358.3,47596,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47596,1,3,0)
;;=3^Emotional Lability
;;^UTILITY(U,$J,358.3,47596,1,4,0)
;;=4^R45.86
;;^UTILITY(U,$J,358.3,47596,2)
;;=^5019475
;;^UTILITY(U,$J,358.3,47597,0)
;;=R44.3^^185^2408^43
;;^UTILITY(U,$J,358.3,47597,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47597,1,3,0)
;;=3^Hallucinations,Unspec
;;^UTILITY(U,$J,358.3,47597,1,4,0)
;;=4^R44.3
;;^UTILITY(U,$J,358.3,47597,2)
;;=^5019458
;;^UTILITY(U,$J,358.3,47598,0)
;;=R46.0^^185^2408^46
;;^UTILITY(U,$J,358.3,47598,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47598,1,3,0)
;;=3^Hygiene,Personal,Very Low Level
;;^UTILITY(U,$J,358.3,47598,1,4,0)
;;=4^R46.0
;;^UTILITY(U,$J,358.3,47598,2)
;;=^5019478
;;^UTILITY(U,$J,358.3,47599,0)
;;=Z91.83^^185^2408^54
;;^UTILITY(U,$J,358.3,47599,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47599,1,3,0)
;;=3^Personal Hx of Wandering
;;^UTILITY(U,$J,358.3,47599,1,4,0)
;;=4^Z91.83
;;^UTILITY(U,$J,358.3,47599,2)
;;=^5063627
;;^UTILITY(U,$J,358.3,47600,0)
;;=A81.9^^185^2408^6
;;^UTILITY(U,$J,358.3,47600,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47600,1,3,0)
;;=3^Atypical Virus Infection of CNS,Unspec
;;^UTILITY(U,$J,358.3,47600,1,4,0)
;;=4^A81.9
;;^UTILITY(U,$J,358.3,47600,2)
;;=^5000414
;;^UTILITY(U,$J,358.3,47601,0)
;;=A81.2^^185^2408^55
;;^UTILITY(U,$J,358.3,47601,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47601,1,3,0)
;;=3^Progressive Multifocal Leukoencephalopathy
;;^UTILITY(U,$J,358.3,47601,1,4,0)
;;=4^A81.2
;;^UTILITY(U,$J,358.3,47601,2)
;;=^5000411
;;^UTILITY(U,$J,358.3,47602,0)
;;=B20.^^185^2408^41
;;^UTILITY(U,$J,358.3,47602,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47602,1,3,0)
;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbance
;;^UTILITY(U,$J,358.3,47602,1,4,0)
;;=4^B20.
;;^UTILITY(U,$J,358.3,47602,2)
;;=^5000555^F02.81
;;^UTILITY(U,$J,358.3,47603,0)
;;=B20.^^185^2408^42
;;^UTILITY(U,$J,358.3,47603,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47603,1,3,0)
;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
;;^UTILITY(U,$J,358.3,47603,1,4,0)
;;=4^B20.
;;^UTILITY(U,$J,358.3,47603,2)
;;=^5000555^F02.80
;;^UTILITY(U,$J,358.3,47604,0)
;;=G10.^^185^2408^44
;;^UTILITY(U,$J,358.3,47604,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47604,1,3,0)
;;=3^Huntington's Disease w/ Dementia w/ Behavioral Disturbances
;;^UTILITY(U,$J,358.3,47604,1,4,0)
;;=4^G10.
;;^UTILITY(U,$J,358.3,47604,2)
;;=^5003751^F02.81
;;^UTILITY(U,$J,358.3,47605,0)
;;=G20.^^185^2408^52
;;^UTILITY(U,$J,358.3,47605,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47605,1,3,0)
;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
;;^UTILITY(U,$J,358.3,47605,1,4,0)
;;=4^G20.
;;^UTILITY(U,$J,358.3,47605,2)
;;=^5003770^F02.81
;;^UTILITY(U,$J,358.3,47606,0)
;;=G20.^^185^2408^53
;;^UTILITY(U,$J,358.3,47606,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47606,1,3,0)
;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
;;^UTILITY(U,$J,358.3,47606,1,4,0)
;;=4^G20.
;;^UTILITY(U,$J,358.3,47606,2)
;;=^5003770^F02.80
;;^UTILITY(U,$J,358.3,47607,0)
;;=G23.1^^185^2408^56
;;^UTILITY(U,$J,358.3,47607,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47607,1,3,0)
;;=3^Progressive Supranuclear Ophthalmoplegia
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2ZD 3809 printed Oct 16, 2024@18:39:34 Page 2
IBDEI2ZD ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,47595,1,4,0)
+2 ;;=4^R42.
+3 ;;^UTILITY(U,$J,358.3,47595,2)
+4 ;;=^5019450
+5 ;;^UTILITY(U,$J,358.3,47596,0)
+6 ;;=R45.86^^185^2408^40
+7 ;;^UTILITY(U,$J,358.3,47596,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,47596,1,3,0)
+10 ;;=3^Emotional Lability
+11 ;;^UTILITY(U,$J,358.3,47596,1,4,0)
+12 ;;=4^R45.86
+13 ;;^UTILITY(U,$J,358.3,47596,2)
+14 ;;=^5019475
+15 ;;^UTILITY(U,$J,358.3,47597,0)
+16 ;;=R44.3^^185^2408^43
+17 ;;^UTILITY(U,$J,358.3,47597,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,47597,1,3,0)
+20 ;;=3^Hallucinations,Unspec
+21 ;;^UTILITY(U,$J,358.3,47597,1,4,0)
+22 ;;=4^R44.3
+23 ;;^UTILITY(U,$J,358.3,47597,2)
+24 ;;=^5019458
+25 ;;^UTILITY(U,$J,358.3,47598,0)
+26 ;;=R46.0^^185^2408^46
+27 ;;^UTILITY(U,$J,358.3,47598,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,47598,1,3,0)
+30 ;;=3^Hygiene,Personal,Very Low Level
+31 ;;^UTILITY(U,$J,358.3,47598,1,4,0)
+32 ;;=4^R46.0
+33 ;;^UTILITY(U,$J,358.3,47598,2)
+34 ;;=^5019478
+35 ;;^UTILITY(U,$J,358.3,47599,0)
+36 ;;=Z91.83^^185^2408^54
+37 ;;^UTILITY(U,$J,358.3,47599,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,47599,1,3,0)
+40 ;;=3^Personal Hx of Wandering
+41 ;;^UTILITY(U,$J,358.3,47599,1,4,0)
+42 ;;=4^Z91.83
+43 ;;^UTILITY(U,$J,358.3,47599,2)
+44 ;;=^5063627
+45 ;;^UTILITY(U,$J,358.3,47600,0)
+46 ;;=A81.9^^185^2408^6
+47 ;;^UTILITY(U,$J,358.3,47600,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,47600,1,3,0)
+50 ;;=3^Atypical Virus Infection of CNS,Unspec
+51 ;;^UTILITY(U,$J,358.3,47600,1,4,0)
+52 ;;=4^A81.9
+53 ;;^UTILITY(U,$J,358.3,47600,2)
+54 ;;=^5000414
+55 ;;^UTILITY(U,$J,358.3,47601,0)
+56 ;;=A81.2^^185^2408^55
+57 ;;^UTILITY(U,$J,358.3,47601,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,47601,1,3,0)
+60 ;;=3^Progressive Multifocal Leukoencephalopathy
+61 ;;^UTILITY(U,$J,358.3,47601,1,4,0)
+62 ;;=4^A81.2
+63 ;;^UTILITY(U,$J,358.3,47601,2)
+64 ;;=^5000411
+65 ;;^UTILITY(U,$J,358.3,47602,0)
+66 ;;=B20.^^185^2408^41
+67 ;;^UTILITY(U,$J,358.3,47602,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,47602,1,3,0)
+70 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbance
+71 ;;^UTILITY(U,$J,358.3,47602,1,4,0)
+72 ;;=4^B20.
+73 ;;^UTILITY(U,$J,358.3,47602,2)
+74 ;;=^5000555^F02.81
+75 ;;^UTILITY(U,$J,358.3,47603,0)
+76 ;;=B20.^^185^2408^42
+77 ;;^UTILITY(U,$J,358.3,47603,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,47603,1,3,0)
+80 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
+81 ;;^UTILITY(U,$J,358.3,47603,1,4,0)
+82 ;;=4^B20.
+83 ;;^UTILITY(U,$J,358.3,47603,2)
+84 ;;=^5000555^F02.80
+85 ;;^UTILITY(U,$J,358.3,47604,0)
+86 ;;=G10.^^185^2408^44
+87 ;;^UTILITY(U,$J,358.3,47604,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,47604,1,3,0)
+90 ;;=3^Huntington's Disease w/ Dementia w/ Behavioral Disturbances
+91 ;;^UTILITY(U,$J,358.3,47604,1,4,0)
+92 ;;=4^G10.
+93 ;;^UTILITY(U,$J,358.3,47604,2)
+94 ;;=^5003751^F02.81
+95 ;;^UTILITY(U,$J,358.3,47605,0)
+96 ;;=G20.^^185^2408^52
+97 ;;^UTILITY(U,$J,358.3,47605,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,47605,1,3,0)
+100 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
+101 ;;^UTILITY(U,$J,358.3,47605,1,4,0)
+102 ;;=4^G20.
+103 ;;^UTILITY(U,$J,358.3,47605,2)
+104 ;;=^5003770^F02.81
+105 ;;^UTILITY(U,$J,358.3,47606,0)
+106 ;;=G20.^^185^2408^53
+107 ;;^UTILITY(U,$J,358.3,47606,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,47606,1,3,0)
+110 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
+111 ;;^UTILITY(U,$J,358.3,47606,1,4,0)
+112 ;;=4^G20.
+113 ;;^UTILITY(U,$J,358.3,47606,2)
+114 ;;=^5003770^F02.80
+115 ;;^UTILITY(U,$J,358.3,47607,0)
+116 ;;=G23.1^^185^2408^56
+117 ;;^UTILITY(U,$J,358.3,47607,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,47607,1,3,0)
+120 ;;=3^Progressive Supranuclear Ophthalmoplegia
